Obese Patients With Untreated Dyslipidemias

Study of Weight-Reducing Effect and Safety of Rimonabant In Obesity in ASIA (RIO-ASIA)

NCT00325546 ·Status: COMPLETED ·Phase: PHASE3

Rimonabant in Abdominally Obese Patients With Impaired Fasting Blood Glucose

NCT00405808 ·Status: TERMINATED ·Phase: PHASE3

Long-Term Effect of 10 mg Versus 20 mg Rimonabant in Overweight or Obese Patients

NCT00678483 ·Status: TERMINATED ·Phase: PHASE3

VIsceral Fat Reduction Assessed by CT-scan On RImonabAnt

NCT00299325 ·Status: COMPLETED ·Phase: PHASE3

Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes

NCT00263042 ·Status: TERMINATED ·Phase: PHASE3

Japanese Dose-Response Study of Rimonabant in Obese Patients

NCT00459004 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors

NCT00458081 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of Rimonabant on Weight Loss and Frequency of Binge Episodes in Obese Patients

NCT00481975 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of ATL-962 in Obese Diabetics

NCT00156897 ·Status: COMPLETED ·Phase: PHASE2

A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients

NCT00391196 ·Status: TERMINATED ·Phase: PHASE3

Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.

NCT00396448 ·Status: TERMINATED ·Phase: PHASE3

A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects

NCT00134199 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Phase 2 Study to Evaluate Safety and Efficacy of RM-493 in Obese Participants

NCT01749137 ·Status: COMPLETED ·Phase: PHASE2

An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without Diabetes

NCT00576667 ·Status: TERMINATED ·Phase: PHASE3

The Effect of Rimonabant on Energy Expenditure, Fat Metabolism and Body Composition

NCT00584389 ·Status: TERMINATED ·Phase: PHASE4

Phase 1b/2a Study to Evaluate Safety and Efficacy of Setmelanotide in Obese Patients

NCT02041195 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

NCT07037433 ·Status: RECRUITING ·Phase: PHASE3

Evaluation of Omarigliptin (MK-3102) in Obese Participants and in Participants With Type 2 Diabetes (MK-3102-004)

NCT01088711 ·Status: COMPLETED ·Phase: PHASE1

A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety

NCT00375401 ·Status: TERMINATED ·Phase: PHASE3

Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS)

NCT00434096 ·Status: TERMINATED ·Phase: PHASE3

Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity

NCT03308721 ·Status: COMPLETED ·Phase: PHASE1

A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients

NCT00483171 ·Status: TERMINATED ·Phase: PHASE3

A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients

NCT00234832 ·Status: COMPLETED ·Phase: PHASE3

Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity

NCT00330525 ·Status: COMPLETED ·Phase: PHASE2

Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity

NCT05579977 ·Status: TERMINATED ·Phase: PHASE2